Teemu Daniel Laajala

11PUBLICATIONS
74CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical mycologyPredictive and prognostic markersMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 17, 2024
DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer.

Majid Momeny, Mari Tienhaara, Mukund Sharma

|Mar 27, 2024
NPEPPS Is a Druggable Driver of Platinum Resistance.

Robert T Jones, Mathijs Scholtes, Andrew Goodspeed

|Jan 23, 2024
MRI-Targeted Prostate Biopsy Introduces Grade Inflation and Overtreatment.

Abderrahim Oussama Batouche, Eugen Czeizler, Timo-Pekka Lehto

|Jul 05, 2023
A harmonized resource of integrated prostate cancer clinical, -omic, and signature features.

Teemu D Laajala, Varsha Sreekanth, Alex C Soupir

|May 24, 2023
Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin.

Florus C de Jong, Teemu D Laajala, Robert F Hoedemaeker

Pageof 2